Leprosy post-exposure prophylaxis risks not adequately assessed

Lancet Glob Health. 2021 Apr;9(4):e400-e401. doi: 10.1016/S2214-109X(21)00046-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Feasibility Studies
  • Humans
  • Leprosy* / epidemiology
  • Leprosy* / prevention & control
  • Post-Exposure Prophylaxis
  • Rifampin*

Substances

  • Rifampin